AzTrials
AzTrials

FibromyalgiaNCT02257034

The Effect of Tai Chi in Treating Fibromyalgia

A study testing Taichi and Dance in people with Fibromyalgia, run by Chengdu PLA General Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To evaluate the effect of Tai chi on Fibromyalgia Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Fibromyalgia
What is being tested?
Taichi and Dance
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
120 participants
Where
1 siteChina
Study dates
Aug 2014to Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 40 years of age or older
  • meeting the classification of FM per the 1990 ACR criteria
  • approval by a healthcare provider for participation

Who cannot join

  • had practiced Tai chi within the past 6 months
  • had exercised >30 min three times weekly for past 3 months
  • could not independently ambulate without assistive devices
  • had BPI pain severity or interference scores less than 5
  • had planned elective surgery during study period
  • were actively involved in health-related litigation
  • were unwilling to keep all treatments/medications steady throughout the study period

Trial locations and contacts

1 site in 1 country.

China1 site
  • General Hospital of Chengdu Military Area Command PLA

    Chengdu, Sichuan, 610083

Other trials in China

About this study

To evaluate the effect of Tai chi on Fibromyalgia

Conditions
Fibromyalgia
Being tested
Taichi, Dance
Medical subject headings
Fibromyalgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TaichiOther

  • DanceOther

Study groups in NCT02257034
Study groupRoleWhat they receive
TaichiExperimentalpatients exercise with Tai chi
Receives: Other: Taichi
ControlSham comparatorpatients under exercise of dance
Receives: Other: Dance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fibromyalgia Impact Questionnaire (FIQ)

    Measured: up to 48 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2014 (estimated)
  2. Study startAug 2014
  3. Primary completionDec 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02257034
Sponsor's protocol ID
TC20140601
Status last verified
Mar 2017
First submitted
2 Oct 2014
Last updated
4 Apr 2017
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Taichi and Dance in people with Fibromyalgia, run by Chengdu PLA General Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fibromyalgia Impact Questionnaire (FIQ) (time frame: up to 48 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in